New drugs acting on the TGFβ pathway could be suitable for use in the treatment of a variety of human diseases ranging from cancer, fibrosis and cardiovascular diseases to metabolic disorders like diabetes and obesity [41]–[47]. The gene discussed is TGFB1; the disease is cardiovascular disorder.